Working… Menu

Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients (SCOL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04778176
Recruitment Status : Recruiting
First Posted : March 2, 2021
Last Update Posted : July 27, 2021
Clintrex Research Corporation
TFS Trial Form Support
Clinical Data Science GmbH
Information provided by (Responsible Party):
SynAgile Corporation

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 14, 2021
Estimated Study Completion Date : December 28, 2021